Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a research report issued on Thursday. A number of other brokerages also recently issued reports on AGIO. Piper Jaffray Companies assumed coverage on Agios Pharmaceuticals in a report on Friday, February 3rd. They issued an “overweight” […]
StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Get Rating) from a sell rating to a hold rating in a research report released on Friday morning. AGIO has been the subject of a number of other research reports. Piper Sandler started coverage on Agios Pharmaceuticals in a research note on Friday, February 3rd. They set […]